Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 04:00PM ET
157.06
Dollar change
-1.20
Percentage change
-0.76
%
IndexS&P 500 P/E46.76 EPS (ttm)3.36 Insider Own0.11% Shs Outstand1.77B Perf Week-5.62%
Market Cap277.35B Forward P/E13.05 EPS next Y12.04 Insider Trans-19.21% Shs Float1.76B Perf Month-6.12%
Income5.95B PEG7.45 EPS next Q3.05 Inst Own72.55% Short Float0.82% Perf Quarter-12.16%
Sales54.40B P/S5.10 EPS this Y1.14% Inst Trans0.10% Short Ratio2.57 Perf Half Y13.43%
Book/sh4.53 P/B34.64 EPS next Y7.14% ROA4.20% Short Interest14.48M Perf Year11.27%
Cash/sh10.23 P/C15.35 EPS next 5Y6.27% ROE55.92% 52W Range130.96 - 182.89 Perf YTD1.35%
Dividend Est.6.24 (3.98%) P/FCF12.69 EPS past 5Y-5.77% ROI8.29% 52W High-14.12% Beta0.58
Dividend TTM6.06 (3.86%) Quick Ratio0.83 Sales past 5Y11.76% Gross Margin68.99% 52W Low19.93% ATR (14)2.87
Dividend Ex-DateApr 12, 2024 Current Ratio0.94 EPS Y/Y TTM-21.01% Oper. Margin31.87% RSI (14)34.32 Volatility1.58% 1.85%
Employees50000 Debt/Eq9.24 Sales Y/Y TTM-4.12% Profit Margin10.94% Recom1.97 Target Price183.08
Option/ShortYes / Yes LT Debt/Eq7.97 EPS Q/Q496.96% Payout220.33% Rel Volume0.65 Prev Close158.26
Sales Surprise3.19% EPS Surprise2.24% Sales Q/Q0.70% EarningsApr 26 BMO Avg Volume5.63M Price157.06
SMA20-3.04% SMA50-6.70% SMA200-0.93% Trades Volume3,689,740 Change-0.76%
Date Action Analyst Rating Change Price Target Change
May-17-24Initiated Cantor Fitzgerald Overweight $200
Jan-29-24Upgrade William Blair Mkt Perform → Outperform
Dec-18-23Downgrade HSBC Securities Buy → Hold
Dec-11-23Upgrade Goldman Neutral → Buy
Nov-09-23Initiated Deutsche Bank Hold $150
Oct-30-23Upgrade Barclays Equal Weight → Overweight $160 → $170
Oct-20-23Resumed UBS Neutral $157 → $150
Sep-29-23Initiated Raymond James Outperform $177
Jul-25-23Initiated William Blair Mkt Perform
Jul-14-23Initiated HSBC Securities Buy $167
Today 08:45AM
May-23-24 04:05PM
02:01PM
09:40AM
May-22-24 08:50PM
05:17PM Loading…
05:17PM
10:24AM
09:48AM
08:42AM
06:45AM
May-20-24 02:47PM
10:58AM
May-17-24 09:38AM
07:30AM
07:11AM
03:30PM Loading…
May-16-24 03:30PM
06:00AM
May-15-24 06:22AM
May-14-24 12:10PM
09:00AM
08:00AM
06:30AM
May-13-24 04:51PM
11:44AM
11:09AM
09:34AM
08:39AM
May-11-24 08:38AM
03:50AM
May-10-24 12:59PM
09:30AM Loading…
09:30AM
May-09-24 03:53PM
07:11AM
May-08-24 02:10PM
10:49AM
09:37AM
08:32AM
08:00AM
May-07-24 04:30PM
02:50PM
02:04PM
10:24AM
May-06-24 02:30PM
08:38AM
08:00AM
May-05-24 01:44PM
May-04-24 01:01AM
May-03-24 12:38PM
May-02-24 12:11PM
03:01AM
May-01-24 01:46PM
01:46PM
09:00AM
Apr-30-24 01:50PM
12:02PM
11:45AM
08:38AM
08:00AM
06:32AM
Apr-29-24 04:06PM
11:24AM
08:37AM
08:24AM
Apr-28-24 06:54PM
06:49PM
07:17AM
04:20AM
Apr-27-24 07:15AM
03:07AM
01:24AM
Apr-26-24 05:31PM
04:08PM
04:07PM
03:15PM
03:04PM
01:30PM
01:04PM
12:10PM
11:52AM
11:02AM
11:02AM
10:30AM
09:58AM
09:16AM
09:11AM
09:03AM
08:45AM
08:07AM
08:06AM
07:44AM
07:43AM
07:36AM
07:35AM
07:00AM
Apr-25-24 04:48PM
10:58AM
08:44AM
08:15AM
08:00AM
Apr-23-24 03:09PM
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Donoghoe NicholasEVP, CHIEF BUS/STRAT OFFICERMar 20 '24Sale176.3021,0823,716,75755,903Mar 22 05:00 PM
Stewart Jeffrey RyanEVP, CHIEF COMMERCIAL OFFICERMar 18 '24Option Exercise61.3626,1101,602,110119,890Mar 20 05:00 PM
Stewart Jeffrey RyanEVP, CHIEF COMMERCIAL OFFICERMar 18 '24Sale178.7958,94910,539,50860,941Mar 20 05:00 PM
RICHMOND TIMOTHY J.EVP, CHIEF HR OFFICERMar 01 '24Option Exercise61.3645,7002,804,15289,517Mar 05 05:30 PM
RICHMOND TIMOTHY J.EVP, CHIEF HR OFFICERMar 01 '24Sale177.2775,68013,415,50313,837Mar 05 05:30 PM
Michael Robert A.PRES & CHIEF OPERATING OFFICERFeb 29 '24Option Exercise58.3021,5601,257,012167,524Mar 01 05:50 PM
Michael Robert A.PRES & CHIEF OPERATING OFFICERFeb 29 '24Sale176.4568,87912,153,95798,645Mar 01 05:50 PM
Siatis Perry CEVP, GC AND SECRETARYFeb 29 '24Sale177.399,8911,754,55510,397Mar 01 05:50 PM
Buckbee Kevin KSVP, CONTROLLERFeb 29 '24Sale176.655,144908,6886,983Mar 01 05:50 PM
GONZALEZ RICHARD ACHAIRMAN OF THE BOARD AND CEOFeb 28 '24Sale177.27138,61624,572,458519,099Mar 01 05:50 PM
Siatis Perry CEVP, GC AND SECRETARYFeb 23 '24Option Exercise137.3613,7531,889,11541,926Feb 27 05:10 PM
Reents Scott TEVP, CHIEF FINANCIAL OFFICERFeb 23 '24Option Exercise61.3614,140867,63041,205Mar 01 05:50 PM
Reents Scott TEVP, CHIEF FINANCIAL OFFICERFeb 23 '24Sale177.4414,1402,509,00227,065Mar 01 05:50 PM
Siatis Perry CEVP, GC AND SECRETARYFeb 23 '24Sale177.5113,7532,441,29528,173Feb 27 05:10 PM
SALEKI-GERHARDT AZITAEVP, CHIEF OPERATIONS OFFICERFeb 21 '24Option Exercise58.8852,8703,112,986296,814Feb 23 05:00 PM
SALEKI-GERHARDT AZITAEVP, CHIEF OPERATIONS OFFICERFeb 21 '24Sale173.7152,8709,184,048243,944Feb 23 05:00 PM
Donoghoe NicholasEVP, CHIEF BUS/STRAT OFFICERDec 26 '23Sale154.722,912450,54555,903Dec 28 05:00 PM
GONZALEZ RICHARD ACHAIRMAN OF THE BOARD AND CEOAug 01 '23Sale148.5860,0008,914,800565,294Aug 02 05:07 PM
GONZALEZ RICHARD ACHAIRMAN OF THE BOARD AND CEOJul 31 '23Sale149.1518,5002,759,275625,294Aug 02 05:07 PM